RFK Jr. pulls $500 million in funding for vaccine development

WASHINGTON (AP) — The Department of Health and Human Services is set to terminate contracts and withdraw funding for certain vaccines that are being developed to combat respiratory viruses such as COVID-19 and the flu.

Robert F. Kennedy Jr. declared on Tuesday that 22 initiatives, amounting to $500 million, focused on developing vaccines through mRNA technology will be halted.

Kennedy’s move to end these projects is the latest step reflecting the vaccine skeptic’s views on vaccinations at the nation’s health agency. He has retracted guidance related to COVID-19 shots, dismissed the committee responsible for recommending vaccines, and avoided giving strong support for vaccinations even as a measles outbreak worsened.

The health secretary criticized mRNA vaccines in a video posted on his social media channels, outlining the rationale for discontinuing projects led by major pharmaceutical companies, including Pfizer and Moderna, which provide protection against viruses like the flu, COVID-19, and H5N1.

“To replace the problematic mRNA programs, we’re focusing on the development of safer, more comprehensive vaccine strategies, such as whole-virus vaccines and new platforms that don’t falter when viruses mutate,” Kennedy stated in the video.

Experts in infectious diseases assert that the mRNA technology used in vaccines is safe, and they attribute its creation during the first Trump administration with mitigating the impact of the 2020 coronavirus pandemic. They cautioned that upcoming pandemics will be more challenging to manage without mRNA assistance.

“I don’t think I’ve seen a more dangerous decision in public health in my 50 years in the business,” said Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations.

He noted mRNA technology offers potential advantages of rapid production, crucial in the event of a new pandemic that requires a new vaccine.

The shelving of the mRNA projects is short-sighted as concerns about a bird flu pandemic continue to loom, said Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia.

“It’s certainly saved millions of lives,” Offit said of the existing mRNA vaccines.

Scientists are using mRNA for more than infectious disease vaccines, with researchers around the world exploring its use for cancer immunotherapies. At the White House earlier this year, billionaire tech entrepreneur Larry Ellison praised mRNA for its potential to treat cancer.

Traditionally, vaccines have required growing pieces of viruses, often in chicken eggs or giant vats of cells, then purifying that material. The mRNA approach starts with a snippet of genetic code that carries instructions for making proteins. Scientists pick the protein to target, inject that blueprint and the body makes just enough to trigger immune protection — producing its own vaccine dose.

In a statement Tuesday, HHS said “other uses of mRNA technology within the department are not impacted by this announcement.”

The mRNA technology is used in approved COVID-19 and RSV shots, but has not yet been approved for a flu shot. Moderna, which was studying a combination COVID-19 and flu mRNA shot, had said it believed mRNA could speed up production of flu shots compared with traditional vaccines.

The abandoned mRNA projects signal a “shift in vaccine development priorities,” the health department said in its statement, adding that it will start “investing in better solutions.”

“Let me be absolutely clear, HHS supports safe, effective vaccines for every American who wants them,” Kennedy said in the statement.

Speaking hours later Tuesday at a news conference in Anchorage, Alaska, alongside the state’s two Republican U.S. senators, Kennedy said work is underway on an alternative.

He said a “universal vaccine” that mimics “natural immunity” is the administration’s focus.

“It could be effective — we believe it’s going to be effective — against not only coronaviruses, but also flu,” he said.

Associated Press writers Lauran Neergaard in Washington, Mike Stobbe in New York and Becky Bohrer in Juneau contributed.

You May Also Like

Trump Takes Center Stage at Great American State Fair Amid Artist Withdrawals

WASHINGTON – The stage is set for a grand celebration of America’s…

Dramatic Rescue Effort Underway for Trapped Men in Flooded Laos Cave; Search Continues for Missing Pair

BANGKOK – Rescue operations in Laos continued Saturday as emergency teams worked…

WHO Director-General Visits Ituri Province in Eastern Congo Amid Escalating Ebola Outbreak

BUNIA – In an urgent response to an escalating health crisis, the…

Trump Set to Appeal Ruling Permitting Importers to Claim Refunds on Invalidated Tariffs

NEW YORK – Businesses across the nation, from large corporations to small…

New Jersey Voters Question Tom Kean Jr.’s Congressional Absence

WESTFIELD, N.J. – As residents of New Jersey convened this week to…

Florida Legislature Greenlights New Tax Regulations: Key Insights for Residents and Businesses

If signed by Gov. DeSantis, provisions take effect on July 1 TALLAHASSEE,…

U.S. Naval Strike Takes Down Suspected Drug Vessel in Eastern Pacific, Resulting in Three Fatalities

WASHINGTON – The United States military reported another strike on Friday targeting…

Hegseth Eases China’s ‘Threat’ Concerns, Reassures Pacific Allies

On Saturday, U.S. Defense Secretary Pete Hegseth reassured allies in the Pacific…

Neighborhood Oak Trees at Risk: HOA Considers Removal Due to Foundation Issues

Residents of a waterfront condominium in Cape Canaveral, Florida, may soon face…

Blue Origin’s New Glenn Rocket Faces Setback at Cape Canaveral: Unpacking the Incident and Future Plans

BREVARD COUNTY, Fla. – A dramatic incident unfolded at Cape Canaveral Space…

U.S. Forces Intercept and Disable Commercial Vessel Attempting Blockade Breach En Route to Iran

WASHINGTON – In a recent development, the U.S. military intercepted another merchant…

Ebola Outbreak in Congo: Experts Highlight Risks of Consuming Wild Game

KINSHASA – In the bustling Masina Market of Kinshasa, the capital of…